{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T22:55:32Z","timestamp":1795042532897,"version":"4.10.2"},"reference-count":36,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T00:00:00Z","timestamp":1559088000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Hoya Corporation","award":["collaborative research PolyU grant H-ZG3B & 1-87LK"],"award-info":[{"award-number":["collaborative research PolyU grant H-ZG3B & 1-87LK"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2020,3]]},"abstract":"<jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To determine if \u2018Defocus Incorporated Multiple Segments\u2019 (DIMS) spectacle lenses slow childhood myopia progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A 2-year double-masked randomised controlled trial was carried out in 183 Chinese children aged 8\u201313 years, with myopia between \u22121.00 and \u22125.00 D and astigmatism \u22641.50 D. Children were randomly assigned to wear DIMS (n=93) or single vision (SV) spectacle lenses (n=90). DIMS lens incorporated multiple segments with myopic defocus of +3.50 D. Refractive error (cycloplegic autorefraction) and axial length were measured at 6month intervals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>160 children completed the study, n=79 in the DIMS group and n=81 in the SV group. Average (SE) myopic progressions over 2 years were \u22120.41\u00b10.06 D in the DIMS group and \u22120.85\u00b10.08 D in the SV group. Mean (SE) axial elongation was 0.21\u00b10.02\u2009mm and 0.55\u00b10.02\u2009mm in the DIMS and SV groups, respectively. Myopia progressed 52% more slowly for children in the DIMS group compared with those in the SV group (mean difference \u22120.44\u00b10.09 D, 95%\u2009CI \u22120.73 to \u22120.37, p&lt;0.0001). Likewise, children in the DIMS group had less axial elongation by 62% than those in the SV group (mean difference 0.34\u00b10.04\u2009mm, 95%\u2009CI 0.22 to 0.37, p&lt;0.0001). 21.5% children who wore DIMS lenses had no myopia progression over 2 years, but only 7.4% for those who wore SV lenses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Daily wear of the DIMS lens significantly retarded myopia progression and axial elongation in myopic children. Our results demonstrated simultaneous clear vision with constant myopic defocus can slow myopia progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT02206217\">NCT02206217<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bjophthalmol-2018-313739","type":"journal-article","created":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T17:19:10Z","timestamp":1559150350000},"page":"363-368","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":589,"title":["Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial"],"prefix":"10.1136","volume":"104","clinical-trial-number":[{"clinical-trial-number":"nct02206217","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6808-5018","authenticated-orcid":false,"given":"Carly Siu Yin","family":"Lam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing Chun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis Yan-yin","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger Pak Kin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel Ka Man","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keigo","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Hatanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Ho","family":"To","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,5,29]]},"reference":[{"key":"2020060209150896000_104.3.363.1","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/S0140-6736(12)60272-4","article-title":"Myopia","volume":"379","author":"Morgan","year":"2012","journal-title":"The Lancet"},{"key":"2020060209150896000_104.3.363.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2016.01.006"},{"key":"2020060209150896000_104.3.363.3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1475-1313.2011.00886.x"},{"key":"2020060209150896000_104.3.363.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(01)01024-7"},{"key":"2020060209150896000_104.3.363.5","doi-asserted-by":"publisher","DOI":"10.1111\/opo.12082"},{"key":"2020060209150896000_104.3.363.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2006.06.050"},{"key":"2020060209150896000_104.3.363.7","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/eye.2013.256","article-title":"Myopia, an underrated global challenge to vision: Where the current data takes us on myopia control","volume":"28","author":"Holden","year":"2014","journal-title":"Eye"},{"key":"2020060209150896000_104.3.363.8","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.12.104034"},{"key":"2020060209150896000_104.3.363.9","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ophtha.2015.11.010","article-title":"Efficacy comparison of 16 interventions for myopia control in children: a network meta-analysis","volume":"123","author":"Huang","year":"2016","journal-title":"Ophthalmology"},{"key":"2020060209150896000_104.3.363.10","first-page":"133","article-title":"Controlling myopia progression in children and adolescents","volume":"6","author":"Smith","year":"2015","journal-title":"Adolesc Health Med Ther"},{"key":"2020060209150896000_104.3.363.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2006.05.062"},{"key":"2020060209150896000_104.3.363.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2011.07.031"},{"key":"2020060209150896000_104.3.363.13","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2015.0043"},{"key":"2020060209150896000_104.3.363.14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ophtha.2018.05.029","article-title":"Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control","volume":"126","author":"Yam","year":"2019","journal-title":"Ophthalmology"},{"key":"2020060209150896000_104.3.363.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2004.08.008"},{"key":"2020060209150896000_104.3.363.16","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.10-5716"},{"key":"2020060209150896000_104.3.363.17","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.07-0383"},{"key":"2020060209150896000_104.3.363.18","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.13-11724"},{"key":"2020060209150896000_104.3.363.19","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.12-9822"},{"key":"2020060209150896000_104.3.363.20","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.14-14250"},{"key":"2020060209150896000_104.3.363.21","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.12-10565"},{"key":"2020060209150896000_104.3.363.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2010.10.035"},{"key":"2020060209150896000_104.3.363.23","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2013-303914"},{"key":"2020060209150896000_104.3.363.24","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/OPX.0000000000000808","article-title":"Myopia control with bifocal contact lenses: a randomized clinical trial","volume":"93","author":"Aller","year":"2016","journal-title":"Optom Vis Sci"},{"key":"2020060209150896000_104.3.363.25","first-page":"2852","article-title":"The Hong Kong progressive lens myopia control study: study design and main findings","volume":"43","author":"Edwards","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2020060209150896000_104.3.363.26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.313.7057.570"},{"key":"2020060209150896000_104.3.363.27","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.02-0816"},{"key":"2020060209150896000_104.3.363.28","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.07-0385"},{"key":"2020060209150896000_104.3.363.29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1475-1313.2008.00608.x"},{"key":"2020060209150896000_104.3.363.30","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.10-6631"},{"key":"2020060209150896000_104.3.363.31","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.11-7769"},{"key":"2020060209150896000_104.3.363.32","doi-asserted-by":"publisher","DOI":"10.1097\/OPX.0b013e3181ea19c7"},{"key":"2020060209150896000_104.3.363.33","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.11-7260"},{"key":"2020060209150896000_104.3.363.34","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1001\/jamaophthalmol.2013.7623","article-title":"Effect of bifocal and prismatic bifocal spectacles on myopia progression in children: three-year results of a randomized clinical trial","volume":"132","author":"Cheng","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"2020060209150896000_104.3.363.35","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/j.clae.2018.03.097","article-title":"3 year effectiveness of a dual-focus 1 day soft contact lens for myopia control","volume":"41","author":"Chamberlain","year":"2018","journal-title":"Contact Lens and Anterior Eye"},{"key":"2020060209150896000_104.3.363.36","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.10-5601"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2018-313739","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T04:59:35Z","timestamp":1601096375000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2018-313739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,29]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,2,21]]},"published-print":{"date-parts":[[2020,3]]}},"alternative-id":["10.1136\/bjophthalmol-2018-313739"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2018-313739","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,29]]}}}